ABEO Abeona Therapeutics Inc.
$5.40
Abeona Therapeutics Inc. (ABEO) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.3% since its last earnings release on August 13, 2026.
Abeona Therapeutics Missed Consensus Estimates
Thursday, August 13, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · 7:30 AM ET
Earnings Whisper
-
vs ($0.14)
Rev est $18.07M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$5.84
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases.
Sector
Healthcare
Industry
Biotechnology
Charts powered in part by Lightweight Charts™ by TradingView.